54307-67-4

Basic information

• Product Name: Benzene, [[2-broMo-1-(chloroMethyl)ethoxy]Methyl]-
• Synonyms: Benzene, [[2-broMo-1-(chloroMethyl)ethoxy]Methyl]-;((1-broMo-3-chloropropan-2-yloxy)Methyl)benzene;(1-Bromomethyl-2-chloro-ethoxymethyl)-benzene;(1-Bromo-1-(2-chloroethoxy)ethyl)benzene
• CAS NO: 54307-67-4
• Molecular Formula: C₁₀H₁₂BrClO
• Molecular Weight: 263.55868
• Mol File: 54307-67-4.mol
• Article Data: 22

Chemical Properties

• Boiling Point: 146-150 °C(Press: 5 Torr)
• Appearance: /
• Density: 1.412±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzene, [[2-broMo-1-(chloroMethyl)ethoxy]Methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, [[2-broMo-1-(chloroMethyl)ethoxy]Methyl]-(54307-67-4)
• EPA Substance Registry System: Benzene, [[2-broMo-1-(chloroMethyl)ethoxy]Methyl]-(54307-67-4)

Safety Data

• Hazardous Substances Data: 54307-67-4(Hazardous Substances Data)

Usage

General Description

"Benzene, [[2-bromo-1-(chloromethyl)ethoxy]methyl]-" is a chemical compound that belongs to the class of benzene and substituted derivatives. It is a bromoethyl ether derivative and an organic compound containing a bromine atom, a chlorine atom, and a benzene ring. Benzene, [[2-bromo-1-(chloromethyl)ethoxy]methyl]- is used in various industries for its potential use as a pharmaceutical intermediate or a liquid crystal compound. It is important to handle this compound with caution due to its potential harmful effects on health and the environment, as well as its flammability. Additional research and testing may be needed to further understand the properties and potential uses of this chemical compound.

Upstream product

• 100-39-0 benzyl bromide 
• 106-89-8 epichlorohydrin 

Downstream Products

• 54166-15-3 diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate 
• 20061-24-9 [3-benzyloxy-1-(hydroxymethyl)cyclobutyl]methanol 
• 84182-46-7 3-(benzyloxy)cyclobutane-1,1-dicarboxylic acid 
• 4958-02-5 3-(benzyloxy)cyclobutane-1-carboxylic acid 
• 1124175-26-3 3-(benzyloxy)cyclobutane-1-carbonyl chloride 
• 141352-51-4 2-(benzyloxy)-7,7-dimethyl-6,8-dioxaspiro<3.5>nonane 
• 156865-32-6 3-(benzyloxy)cyclobutane-1-methanol 
• 128041-57-6 3α-(benzyloxy)cyclobutane-1β-methanol 
• 141352-64-9 3α-(benzyloxy)cyclobutane-1α-methanol 
• 141352-63-8 1α-benzyloxy-3β-carbethoxy-cyclobutane 
• 141352-62-7 ethyl 3α-(benzyloxy)cyclobutane-1α-carboxylate 
• 141352-66-1 1α-(benzyloxy)-3β-<((tert-butyl)diphenylsilyloxy)methyl>cyclobutane 
• 141352-65-0 1α-(benzyloxy)-3α<((tert-butyl)diphenylsilyloxy)methyl>cyclobutane 
• 1349185-23-4 2-(3-(benzyloxy)cyclobutyl)-1H-benzo[d]imidazole 

Relevant articles and documents

Synthesis and in vitro antitumour activity of carboplatin analogues containing functional handles compatible for conjugation to drug delivery systems

We describe herein the synthesis of a series of carboplatin derivatives with different functional groups at position 3 of the cyclobutane ring. This pharmacomodulation approach aims at facilitating the vectorisation of these analogues, via their subsequen

Synthesis and anticancer activity of diam(m)ine platinum(II) complexes with 3-oxo-cyclobutane-1,1-dicarboxylate as the leaving group

Four water-soluble dia(m)mine platinum complexes with 3-oxo-cyclobutane- 1,1-dicarboxylate as the leaving group have been synthesized. These compounds were evaluated for their in vitro anticancer activity against three human A549, SK-OV-3, and HT-29 cance

COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS

The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.